01

Tempo Therapeutics Wins $2.25M NIH SBIR Grant for MAP Wound Healing

Tempo Therapeutics secured a $2.25 million NIH SBIR grant to advance its MAP™ platform for complex wound healing, adding federal backing to tissue-engineered wound repair.